CXCL16: C-X-C Motif Chemokine Ligand 16

A transmembrane chemokine involved in immune surveillance, atherosclerosis, and cancer progression.

Gene Information Card

Symbol CXCL16
Full Name C-X-C motif chemokine ligand 16
Gene Type protein-coding
Chromosomal Location 17p13.2
NCBI Gene ID 58191 ncbi.nlm.nih.gov/gene/58191
Ensembl ID ENSG00000161921
UniProt ID Q9H2A7
OMIM ID 605398
HGNC ID 16642
Aliases SR-PSOX, CXCLG16, SCYB16

Description

CXCL16 encodes a transmembrane chemokine that exists in both membrane-bound and soluble forms. The membrane-bound form acts as an adhesion molecule and scavenger receptor for oxidized low-density lipoprotein (oxLDL), while the soluble form functions as a chemoattractant for cells expressing CXCR6, including activated T cells and natural killer T cells. CXCL16 is involved in inflammatory responses, atherosclerosis, and tumor immunity.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Atherosclerosis CXCL16 mediates oxLDL uptake by macrophages, promoting foam cell formation and plaque development. PMID: 15123670, 17921315
Coronary artery disease Elevated soluble CXCL16 levels correlate with disease severity and inflammatory markers. PMID: 18645042
Rheumatoid arthritis CXCL16 is upregulated in synovial tissue and contributes to T-cell recruitment and joint inflammation. PMID: 15542592
Prostate cancer CXCL16-CXCR6 axis promotes tumor cell proliferation, migration, and metastasis. PMID: 18245495
Breast cancer CXCL16 expression is associated with tumor progression and poor prognosis. PMID: 23901062

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.3 Medium
Spleen 10.8 Medium
Lung 8.5 Medium
Small intestine 7.2 Low
Liver 5.1 Low
Heart 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
THP-1 (monocyte) 15.2 High expression; upregulated by oxLDL
HUVEC (endothelial) 9.8 Constitutive expression
HeLa (cervical cancer) 6.3 Moderate expression
A549 (lung cancer) 4.7 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.301G>A (p.Gly101Arg) Missense 0.01% (gnomAD) Unknown functional impact
c.487C>T (p.Arg163Trp) Missense 0.005% (gnomAD) Potential loss of chemotactic activity
c.614A>G (p.Asn205Ser) Missense 0.02% (gnomAD) No known disease association
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in CXCL16.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in CXCL16.

Dominant Negative (DN)

No dominant-negative mutations reported for CXCL16.

Pathways

Chemokine signaling pathway (KEGG: hsa04062)
Cytokine-cytokine receptor interaction (KEGG: hsa04060)
Toll-like receptor signaling pathway (KEGG: hsa04620)
NF-kappa B signaling pathway (KEGG: hsa04064)

Protein Summary

CXCL16 is a 254-amino acid transmembrane protein with an N-terminal chemokine domain, a mucin-like stalk, a transmembrane domain, and a short cytoplasmic tail. It is synthesized as a membrane-bound molecule that can be cleaved by ADAM10 and ADAM17 to release a soluble chemokine. The soluble form binds to CXCR6, while the membrane-bound form acts as a scavenger receptor for oxLDL. The protein is expressed on dendritic cells, macrophages, endothelial cells, and smooth muscle cells.

Related Products

Product name Cat.No. Species Gene ID
CXCL16 Knockout HEK293 Cell Line EDJ-KQ51594 Human 58191 Details Get a Quote
CXCL16 Knockout HeLa Cell Line EDJ-KQ56933 Human 58191 Details Get a Quote
CXCL16 Knockout A-549 Cell Line EDJ-KQ65439 Human 58191 Details Get a Quote
CXCL16 Knockout HCT 116 Cell Line EDJ-KQ73877 Human 58191 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: